Scale-up/Technology Transfer

Drug Delivery | Injectables | Scale-up/Technology Transfer

Selecting a CMO Partner for Sterile Injectable Manufacturing

Jubilant HollisterStier’s Value Proposition for Customers

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer

Chimeron Bio Selects Mfg. Partner FUJIFILM Diosynth Biotechnologies

To scale up drug substance manufacturing process at cGMP manufacturing facility in College Station, TX for IND-enabling work.

04.12.22

Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Information Technology | Scale-up/Technology Transfer

DCAT Week Innovation Leaders Program Highlights

Aamir Malik of Pfizer discusses the role of mRNA in vaccines and future drug development, partnerships, and the role of manufacturing in product innovation.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 04.04.22

Capsules | Drug Development | Formulation Development | Scale-up/Technology Transfer

Quickly Create Custom Oral Delivery Systems And Reduce Time To Market With Adaptdose™

Adare's Adaptdose™ technology can help streamline your project's development time and help get you to market faster.

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Novartis, Carisma Ink Mfg. Pact for HER 2 Targeted CAR-M Cell Therapy

Initial agreement covers reservation of Novartis' state-of-the-art cell and gene facility in Morris Plains, NJ.

03.11.22

Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer

Actym Therapeutics and Wacker Biotech Sign Manufacturing Contract

For Actym's lead candidate for the treatment of solid tumors.

03.10.22

Flow Eighteen38 Expands Production and Biophysical Capabilities

Investment of $5.5mn supports expansion of services to include pre-CMC stages for faster and successful biotherapeutics development.

03.08.22

INCOG Biopharma Reaches Another Expansion Milestone

Completes analytical and quality control testing laboratory and technology transfer suite at its headquarters in Fishers, Indiana.

03.04.22

cGMP Manufacture | Scale-up/Technology Transfer

Challenges and Solutions in Viral Vector Manufacturing

The accelerated pathway through the clinic of viral vector-based cell and gene therapies puts pressure on developers to find a skilled partner.

Sponsored released by MilliporeSigma 03.03.22

Ray Therapeutics, Forge Biologics Enter Gene Therapy Mfg. Pact

Forge will provide adeno-associated viral process development, scale-up engineering and cGMP manufacturing services for Ray’s program, Ray-001.

03.01.22

Drug Development | Scale-up/Technology Transfer

Finding the Right CDMO Partner for Tech Transfer

Avoid Risks and Delays in Bringing your Drug to Market

Humanigen and Cenexi Collaborate to Manufacture Lenzilumab in France

CDMO Cenexi to become preferred drug product supplier for France and the EU.

02.09.22

APIs | cGMP Manufacture | Excipients | Process Development | Scale-up/Technology Transfer

CDMO & CMO

tempContent

APIs | Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer

Cyxone Inks API Deal with European CDMO

Takes next step in multiple sclerosis program engaging CDMO for production of drug candidate T20K.

01.20.22

Treadwell Therapeutics and CDMO Genezen Enter Cell Therapy Partnership

Will advance Treadwell’s T cell receptor-based cell therapy pipeline.

01.20.22

Biologics, Proteins, Vaccines | Process Development | Scale-up/Technology Transfer

Modification of Virus Spiking Procedures for Continuous Processes

This white paper demonstrates the feasibility of novel virus spiking strategies to meet the needs of continuous processes.

Sponsored released by MilliporeSigma 12.10.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

BrainStorm, Catalent Complete Tech Transfer for NurOwn

Autologous cell therapy for the treatment of ALS and PMS will be manufactured at Catalent’s 32,000 sq.-ft. cell therapy manufacturing facility in Houston.

12.07.21

cGMP Manufacture | Drug Delivery | Scale-up/Technology Transfer

Sustained Release Microspheres: Achieving Success from Post-Feasibility to GMP Manufacturing

This webcast will outline the typical steps Oakwood Labs takes during post-feasibility, scale-up, technology transfer, and Phase I clinical batch production.

11.09.21